Archive for category Media Coverage

Woman with Rett syndrome dies just 17 months after sexual assault

The health of a 27-year-old with Rett syndrome deteriorated rapidly in the months after an August 2010 attack at a respite centre by a serial offender. A neurologist’s report had characterized the effects of the assault on the young woman as post traumatic stress disorder:

Storified by Rett Dad

Woman with Rett syndrome dies just 17 months after sexual assault

The health of a 27-year-old with Rett syndrome deteriorated rapidly in the months after an August 2010 attack at a respite centre by a serial offender. A neurologist’s report had characterized the effects of the assault on the young woman as post traumatic stress disorder:

Other stories by RettDad on 
 ➜



Rett father reviews the upcoming Fox drama “Touch” for the New York Times

Neil Genzlinger, whose daughter Abby has Rett syndrome, is an American playwright, editor, book reviewer, and theatre and television critic. He writes for The New York Times, where he’s a copy editor. His reviews sometimes include his unique perspective on Rett syndrome. Here’s his latest:

Storified by Rett Dad

Rett father reviews the upcoming Fox drama "Touch" for the New York Times

Neil Genzlinger, whose daughter Abby has Rett syndrome, is an American playwright, editor, book reviewer, and theatre and television critic. He writes for The New York Times, where he’s a copy editor. His reviews sometimes include his unique perspective on Rett syndrome. Here’s his latest:

Other stories by RettDad on 
 ➜



Rett Syndrome benefit concert in Boise, Idaho rakes in $17000 for IRSF

This article illustrates how a local television news story provided significant momentum for concert ticket sales that were initially slow:

Storified by Rett Dad

Rett Syndrome benefit concert in Boise, Idaho rakes in $17000 for IRSF

This article illustrates how a local television news story provided significant momentum for concert ticket sales that were initially slow:

Other stories by RettDad on 
 ➜



Tags: ,

Rett Press: Major Donation to Benefit Texas Children’s Neurological Research Institute

HOUSTON (June 19, 2007) – Texas Children’s Hospital today announced a $500,000 donation from Enbridge Energy Company, Inc. to benefit the Texas Children’s Neurological Research Institute, the world’s first dedicated pediatric neurological research facility. 

“This generous gift propels Texas Children’s Hospital’s efforts to perform groundbreaking research that is designed to lead to innovative treatment options for the millions of lives affected by neurological disorders,” said Dr. Huda Zoghbi, director, Texas Children’s Neurological Research Institute. “The Enbridge contribution is timelier than ever with nearly 450 million people worldwide affected with neurological diseases, 14 million of whom are America’s youth. This gift will not only lead to advances that will help patients with neurological disorders, but will serve as an investment in the future of our children.”  

The number of people afflicted by neurological disorders such as Rett syndrome, Down syndrome, autism, cerebral palsy, epilepsy and learning disabilities is on the rise.  These diseases are estimated to exceed half a trillion dollars annually in healthcare expenditures, lost productivity and related economic costs.  Brain-related disorders account for the majority of our nation’s long-term care costs and, when combined with psychiatric disorders, account for more hospitalization and prolonged care than almost all other diseases combined.

“Enbridge is committed to supporting key health initiatives in the North American communities where our employees live and work,” said Stephen J.J. Letwin, managing director, Enbridge Energy Company, Inc.  “We are proud to invest in this innovative neurological facility at Texas Children’s Hospital, which is pioneering cutting-edge research and treatment advances that ultimately benefit children worldwide.”

Houston is the headquarters for Enbridge’s worldwide natural gas transportation businesses and for two of Enbridge’s three U.S. publicly traded entities, Enbridge Energy Partners, L.P. and Enbridge Energy Management, L.L.C.

Texas Children’s Hospital, one of the top pediatric organizations in the world, recently announced that it is investing $1.5 billion over a four-year period in initiatives to secure its role as a pre-eminent pediatric institution and to anticipate the future of children’s health regionally, nationally and internationally. This is the largest expansion program ever by a single children’s hospital.

The planned initiatives, all of which are targeted for completion by 2010, focus largely on research and accessibility, two areas which the Texas Children’s board and its leadership believe are the keys to rapidly translating science into quality clinical care for children, as well as making that quality care accessible to all patients. Major projects include the creation of a comprehensive neurological research institute, the formation of a maternity center, expansion of existing research facilities and the development of one of the largest pediatric hospitals in a suburban setting

“This investment is not about buildings; it is about the responsibility we as a leader in pediatrics have to accelerate the translation of research into effective treatments,” said Mark A. Wallace, chief executive officer of Texas Children’s Hospital. “Corporate partners like Enbridge make it possible for us to commit the necessary resources to change the lives of countless children and families, in Houston and throughout the world.”

The Texas Children’s Neurological Research Institute will be the first comprehensive pediatric neurological research center of its kind in the world devoted to collaborative, unified efforts to understand the unique issues of the child’s brain structure, development patterns and related diseases.

The institute will combine research, treatment and education, assisting families with children suffering cognitive disorders and scientists committed to finding treatments and cures. Additionally, because so much of this work will be done using genetic models of neurodevelopmental and neurodigenerative diseases, it is anticipated that findings will have a major impact on adult diseases such as Alzheimer and Parkinson diseases.

About Texas Children’s Hospital:
As one of the nation’s largest pediatric hospitals, Texas Children’s Hospital is renowned for its expertise and breakthrough development in the treatment of cancer, premature infants, cardiogenic disorders, diabetes, asthma, HIV/AIDS and attention-related disorders.   Since opening its doors in 1954, the Texas Children’s Hospital has cared for more than 1 million children from every corner of the world and has had more than 2 million patient encounters a year.  Internationally recognized, the hospital is ranked in the top five among children’s hospitals by both Child and U.S. News and World Report. 
 
About Enbridge Energy Company, Inc
Enbridge Energy Company, Inc., is an indirect wholly owned subsidiary of Enbridge Inc. of Calgary, Alberta and is the general partner of Enbridge Energy Partners, L.P. (www.enbridgepartners.com) (the “Partnership”), which owns and operates a diversified portfolio of crude oil and natural gas transportation systems in the United States. The Partnership’s principal crude oil system is the largest transporter of growing oil production from western Canada. The system’s deliveries to refining centers in the U.S. Midwest account for approximately 12 percent of total U.S. oil imports; while deliveries to Ontario, Canada satisfy approximately 60 percent of refinery demand in that region. The Partnership’s natural gas gathering, treating, processing and transmission assets, which are principally located onshore in the active Mid-Continent and Gulf Coast area, deliver more than 2 billion cubic feet of natural gas daily. Enbridge Energy Management, L.L.C. (www.enbridgemanagement.com) manages the business and affairs of the Partnership and its sole asset is an approximate 14 percent interest in the Partnership. For more about Enbridge in the United States, go to www.enbridgeUS.com.

Rett Press: Year-round special education program may end

Source

Grand Rapids Press, Grand Rapids, MI, circulation 133,000

Excerpt

Progress comes slowly for Maiya Novitsky, a 4-year-old with Rett syndrome. Her parents consider just maintaining her current level of ability an accomplishment. But her father, Scott Novitsky, said he is worried Maiya — and other students with severe disabilities — will regress dramatically if she is denied year-round schooling because of a proposed change in state Education Department rules.

"We can see that she’s learning and making gains," Novitsky, of Walker, said. "But if we’re told that she has to take the summer off, they’re going to have to go back and redo everything in the fall. I just don’t know why they would want to do that."

But educators and special education advocates said the proposed change, which would bring the state in line with national standards, should not hinder students who truly benefit from extended time in the classroom.

Article Link

Year-round special education program may end (opens in new window)

Publisher’s Note

This is a good example of how to use a topic that is of current interest to a wider audience to get the word out about Rett Syndrome. The issue in Michigan is that legislators are proposing that a child’s Individual Education Planning (IEP) “committee” be the determining body as to whether a child would receive an extended school year education. Currently that is a mandate in Michigan for all students in special education programs, but legislation would change this. The challenge with this is that it creates a situation whereby the IEP team may end of voting on the issue to reach consensus and the parent usually has just one vote, compared with the school district representatives who form a majority of members on an IEP team. The only recourse if a parent disagrees with the District on any education related issue is to file a costly and lengthy appeal, called a “Fair Hearing”, with an Administrative Law Judge.

Kudos to Scott Novitsky for getting the word out about Rett Syndrome to an audience of 133,00 subscribers and for making the general public aware of this vital educational need.

RSRF and IRSA merge to form the International Rett Syndrome Foundation

Publisher’s note:

This is exciting news for the entire Rett Syndrome Community! As members of IRSA and long time supporters of RSRF, we look forward to being of service to this newly combined organization. Here is the press release in its entirety:

News Release:

Monday, June 04, 2007

Rett Syndrome News Release

For Immediate Release
June 4, 2007

Contact: Kathryn Kissam
804.741.3687
804.519.6231
kkissam@comcast. net

International Rett Syndrome Association and Rett Syndrome Research
Foundation Announce Merger Agreement to Form International Rett Syndrome
Foundation

New Organization to Focus on Research, Family Support, Awareness and
Advocacy

Cincinnati, Ohio – The International Rett Syndrome Association (IRSA) and
the Rett Syndrome Research Foundation (RSRF) today announced the intent to
merge their organizations to form the International Rett Syndrome Foundation
(IRSF).

“The rapid increase in scientific knowledge and pace of innovation in the
field of Rett syndrome research and treatment call for increased
coordination, increased funding and the development of a solid,
comprehensive research repository,” said Kathryn Schanen Kissam, chairman of
the board of IRSA. “By joining forces, we are able to combine the unique
expertise of IRSA and RSRF to better serve the individuals with Rett
syndrome and their families.”

“Both RSRF and IRSA have made significant contributions to the advancement
of understanding in Rett syndrome,” said Steve Gallucci, chairman of the
board of RSRF. “We are looking forward to the many opportunities that will
develop from the merging of our organizations and our mutual determination
to make a meaningful difference in the lives of those who have been touched
by Rett syndrome.”

The merger, which has been unanimously approved by both organizations’
boards, is expected to close around July 1 following the completion of
appropriate due diligence and a two-thirds vote of approval by IRSA’s
members. IRSA will declare a special membership meeting to be held at IRSA’s
offices on June 27 at 9:00 a.m.; a proxy vote will be mailed to all members
on June 4.

“I applaud the members of the governing boards of IRSA and RSRF for their
hard work and due diligence at this pivotal point in the history of Rett
syndrome. It has been my privilege to initiate the Rett syndrome movement,
and my greatest honor to see others who share the same determination and
passion join the cause,” said Kathy Hunter, president and founder of IRSA.
Hunter, who will retire from her full-time staff position with IRSA when the
merger is complete, will continue to work for the new organization in a
part-time position as Ambassador, continuing to provide ongoing support
services to families.

The core mission of IRSF will be to fund research for treatments and a cure
for Rett syndrome and to enhance the overall quality of life for those
living with Rett syndrome by providing information, programs and services.
IRSF will also place great importance on advocacy and raising awareness
about individuals with Rett syndrome so the scientific and medical
communities, along with policy-makers, educators, caregivers and the general
public, are better informed about Rett syndrome and motivated to help
research efforts. 

Chuck Curley, the executive director of RSRF, will be the future executive
director of IRSF. Curley cited the critical progress made by a recent
landmark study, in which the symptoms of Rett syndrome (RTT) were reversed
in a genetic mouse model, as one example of the types of critical research
IRSF will support in the future. 

“Continuing research to find a cure and treatments for Rett syndrome is
absolutely imperative, but also expensive,” Curley said. “This merger
empowers us to leverage significant revenue growth created by shared
fundraisers, collaborative minds, broader resources and combined best
practices to create one strong, unified leader in the search for a cure
while providing support services to families impacted by this disorder.”

The IRSF board of directors will be formed with six people chosen by IRSA’s
board and six chosen from RSRF’s board. Kissam will serve as chairman of
IRSF. As noted, Curley will serve as Executive Director of IRSF. Other
executive staff appointments include Monica Coenraads, who will serve as
Biomedical Research Director, and Paige Nues, who will serve as Family
Support Director.

IRSF’s executive offices will be located at the RSRF location in Cincinnati,
Ohio, with family support services operating from IRSA’s offices in Clinton,
MD. IRSF’s web site will be www.rettsyndrome. org.

About Rett Syndrome
Rett syndrome is a neurological disorder which predominately impacts girls.
While there are nearly 4,000 known cases of Rett syndrome in the United
States, the disorder is genetically linked to more widespread neurological
disorders such as autism, mental retardation and schizophrenia. Rett
symptoms begin to manifest between the first six to eighteen months of life
and eventually incapacitates the affected children so that they cannot
survive without constant care. The disorder causes seizures, respiratory and
gastrointestinal abnormalities, and a variety of muscular and motor
impairments.

About IRSA
The International Rett Syndrome Association (IRSA), founded in 1984, is the
world’s oldest and most comprehensive non-profit organization dedicated to
providing thorough and accurate information about Rett syndrome, offering
informational and educational family support, and stimulating research aimed
at finding the cause of Rett syndrome and methods for its prevention,
control and cure. The IRSA’s mission is to provide a better future for girls
with Rett syndrome. The Association has members in all 50 states and 72
foreign countries. For more information please visit www.rettsyndrome. org,
or call
1-800-818-RETT.

About RSRF
The Rett Syndrome Research Foundation was founded in late 1999 by a
passionate group of parents who were committed to funding research aimed at
finding treatments and a cure for Rett syndrome. Today RSRF is the world’s
leading private funder of Rett research. In the last five years RSRF has
funded 104 projects at premiere institutions totaling over $11 million. The
foundation has proven to be fiscally responsible by directing 97% of each
dollar donated directly to program services and was awarded Charity
Navigator’s prestigious 4-Star rating. For more information please visit
www.rsrf.org, or call
1-513-874-3020.